CHDI Foundation Reagents Registration Request
Welcome to the CHDI Foundation Reagents Registration Portal. Please complete the questionnaire below. Once you have completed the questionnaire, click on the
Submit Completed Request
button to submit the questionnaire to CHDI Foundation, and an email will be sent to you confirming receipt of your submission.
Note that you can submit up to 30 reagents at one time using this form.
Please do not submit individual submissions unless you have been directed to do so by your Foundation Science Director or Program Manager; additional buttons will display once you have entered data for at least one reagent to facilitate the rapid entry of additional reagents.
If you are unable to complete the questionnaire in this session, you may save your work by clicking on the
Save Draft Request
button, and an email will be sent to you with instructions as to how to retrieve your partially completed questionnaire.
Please be advised that the submission of a completed questionnaire is obligatory and it will take a minimum of 10 business days to process. If you have any questions and/or concerns please contact the Foundation Scientific Director associated with your collaboration or alternatively you may contact Mithra Mahmoudi (
mithra.mahmoudi@chdifoundation.org
).
Submit Completed Request
Save Draft Request
Cancel
Submitter Information
*
Your Name
*
Your Email
*
Your Institution
*
CHDI Contact
Make a Selection...
Andrew Wood
Balajee Somalinga
Brinda Prasad
Carl Meinhof
Dan Felsenfeld
David Howland
Deanna Marchionini
Docia Demmin
Dorian Pustina
Douglas Macdonald
Edith Monteagudo
Emily Gantman
Faez Siddiqi
George McAllister
Haiying Tang
Hilary Wilkinson
Jamie Hamilton
Jamie Levey
Jeff Aaronson
Jen Ware
Jian Chen
Jim Rosinski
John Warner
Jonathan Bard
Julien Boudet
Liliana Menalled
Liz Doherty
Longbin Liu
Matthew Roche
Mette Skinbjerg
Michael Finley
Mithra Mahmoudi
Natallia Kalinava
Neha Sinha
Paolo Beuzer
Ramee Lee
Rebecca Fuller
Richard Chen
Robert Doot
Roger Cachope
Seung Kwak
Swati Sathe
Tasir Haque
Thomas Vogt
Vahri Beaumont
Vinod Khetarpal
CHDI Contact Email
Make a Selection...
Andrew Wood
Balajee Somalinga
Brinda Prasad
Carl Meinhof
Dan Felsenfeld
David Howland
Deanna Marchionini
Docia Demmin
Dorian Pustina
Douglas Macdonald
Edith Monteagudo
Emily Gantman
Faez Siddiqi
George McAllister
Haiying Tang
Hilary Wilkinson
Jamie Hamilton
Jamie Levey
Jeff Aaronson
Jen Ware
Jian Chen
Jim Rosinski
John Warner
Jonathan Bard
Julien Boudet
Liliana Menalled
Liz Doherty
Longbin Liu
Matthew Roche
Mette Skinbjerg
Michael Finley
Mithra Mahmoudi
Natallia Kalinava
Neha Sinha
Paolo Beuzer
Ramee Lee
Rebecca Fuller
Richard Chen
Robert Doot
Roger Cachope
Seung Kwak
Swati Sathe
Tasir Haque
Thomas Vogt
Vahri Beaumont
Vinod Khetarpal
Related Materials Management Workflow
Please note that we request that all vials are labeled with the following information: Foundation ID, Material Name, Volume/Concentration in Vial, Date, Prepared by Name/Institution
Reagents Information
(click on
for help entering data in the appropriate field)
# Reagents
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Reagent #1
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #2
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #3
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #4
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #5
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #6
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #7
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #8
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #9
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #10
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #11
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #12
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #13
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #14
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #15
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #16
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #17
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #18
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #19
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #20
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #21
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #22
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #23
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #24
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #25
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced
*
Is this Material a modification/derivative/progeny of a Material collected from a participant in a CHDI funded Clinical Study?
Yes
No
*
Clinical Study under which the Material was collected
Make a Selection...
COHORT
Enroll-HD
HDClarity
HDSA
MITO-HD
MTM
REGISTRY
Track-HD
*
Is this Material a modification/derivative of a Foundation Provided Material?
Yes
No
*
Foundation Provided Material ID
*
Date Lot Made
*
Date Lot Aliquoted/Stored
*
Number of Vials Made/Stored
*
Volume per Vial
*
Concentration per Vial
*
Storage Condition
4°C
-20°C
-80°C
LN2
Other
*
Provide details
*
Host Species
*
Host Strain
*
Tissue of Origin
*
Is cell line a hybridoma?
Yes
No
*
Isotype
Monoclonal
Polyclonal
Other
*
Provide details
*
Isotype Subclass
*
Target Protein Name
*
Is there a corresponding blocking Peptide?
Yes
No
*
Blocking Peptide Material Name
*
Is there a corresponding blocking Antibody?
Yes
No
*
Blocking Antibody Material Name
*
Species Reactivity
*
Specificity Notes
*
Validated Applications and Dilution
*
Engineered DNA Construct Used
*
Induction System Utilized
*
Karyotype
*
Immortalization Method Used
*
Passage Number
*
Complete Growth Medium
*
Temperature
*
Atmosphere
*
Subcultivation Ratio
*
Doubling Time
*
Max Tolerable Cell Density or Confluency
*
Medium Renewal
*
Appearance/Morphology
*
Growth Properties
*
In which Competent Cells
*
Vector Name
*
Vector Map with proper alignment
Vector Map Image
*
Cloning Sites
*
Insert Size
*
Recommended Sequencing Primer Set
*
Immunogen/Epitope/Sequence
Sequence Image
*
Format
Affinity Purified
Protein A Purified
Protein G Purified
Ascites
Serum
Supernatant
Purified
Glycerol Stock
Crude
Other
*
Provide details
*
Preparation/Diluent/Formulation
*
Freeze Medium
*
Safety Notes
Literature Reference
*
Protocol
Supporting Data
Supporting Data Image
*
# Files Additional Information
None
1
2
3
4
5
Additional Information 1
Additional Information 2
Additional Information 3
Additional Information 4
Additional Information 5
Add Different Reagent
Add Similar Reagent
Remove Reagent
Reagent #26
*
Material Type
Antibody
Antisense Oligonucleotide
Cell Line
DNA
Peptide
Protein
RNA
Stem Cell Line
Virus
Repository ID
Material Submitter ID
*
Material Name
Material Alias
*
Material Description
*
Date Originally Created/Produced